CN Patent

CN108530337B — 一种可选择性抑制胃癌细胞的吲哚酰胺类化合物

Assigned to University of South China · Expires 2020-11-03 · 6y expired

What this patent protects

本发明公开了一种可选择性抑制胃癌细胞的吲哚酰胺类化合物，其能够选择性抑制胃癌细胞，尤其是选择性抑制MGC‑803(人胃癌细胞)细胞株。因而，可以用做选择性治疗胃癌的药物，具有良好的开发前景。

USPTO Abstract

本发明公开了一种可选择性抑制胃癌细胞的吲哚酰胺类化合物，其能够选择性抑制胃癌细胞，尤其是选择性抑制MGC‑803(人胃癌细胞)细胞株。因而，可以用做选择性治疗胃癌的药物，具有良好的开发前景。

Drugs covered by this patent

Patent Metadata

Patent number
CN108530337B
Jurisdiction
CN
Classification
—
Expires
2020-11-03
Drug substance claim
No
Drug product claim
No
Assignee
University of South China
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.